Mid Carolina Cardiology Research
Charlotte, North Carolina, United States
Cardiologist in Charlotte, North Carolina
1718 E 4th St #501, Charlotte, NC 28204
About Mid Carolina Cardiology Research
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Boston Scientific Corporation
1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
1
Uppsala University
1
Clinical Trials at Mid Carolina Cardiology Research
During the past decade, Mid Carolina Cardiology Research conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on
average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
2006-10-04
2016-04-12
Completed
24,081
Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction
2017-11-23
2023-12-01
Recruiting
3,200
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Mid Carolina Cardiology Research"
#1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator, "Karolinska University" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Mid Carolina Cardiology Research
According to Clinical.Site data, the most researched conditions in "Mid Carolina Cardiology Research" are
"Arthritis, Rheumatoid" (1 trials), "Heart Failure With Preserved Ejection Fraction" (1 trials) and "Tachycardia, Ventricular" (1 trials). Many other conditions were trialed in "Mid Carolina Cardiology Research" in a lesser frequency.
Clinical Trials Intervention Types at Mid Carolina Cardiology Research
Most popular intervention types in "Mid Carolina Cardiology Research" are "Drug" (2 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Ibuprofen" (1 trials), "Naproxen" (1 trials), "S-ICD System" (1 trials), "Spironolactone" (1 trials) and "Standard care" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Mid Carolina Cardiology Research
The vast majority of trials in "Mid Carolina Cardiology Research" are
3 trials for "All" genders.
Clinical Trials Status at Mid Carolina Cardiology Research
Currently, there are NaN active trials in "Mid Carolina Cardiology Research".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Mid Carolina Cardiology Research,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Mid Carolina Cardiology Research, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".